Sollus Therapeutics, Inc.

Chapel Hill, NC

UEI
L6W7MCAYEBE3
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
114 Winsome Ln, Chapel Hill, NC 27516, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Sollus Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of a modular customizable screening platform for chimeric antigenreceptor optimization - project summary… Grant · R41TR006357 National Center for Advancing Translational Sciences $322,576

Quick answers

What is Sollus Therapeutics, Inc.'s UEI?

Sollus Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is L6W7MCAYEBE3.

Where is Sollus Therapeutics, Inc. located?

Sollus Therapeutics, Inc.'s physical address in SAM.gov is 114 Winsome Ln, Chapel Hill, NC 27516, USA.

Is Sollus Therapeutics, Inc. registered in SAM.gov?

Yes. Sollus Therapeutics, Inc.'s SAM.gov registration is active through August 18, 2027.

What is Sollus Therapeutics, Inc.'s most recent federal award?

Sollus Therapeutics, Inc.'s most recent federal grant award is Development of a modular customizable screening platform for chimeric antigenreceptor optimization - project summary… (R41TR006357), from National Center for Advancing Translational Sciences, on July 1, 2026.

On GovTribe

See Sollus Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login